Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Pricing & Reimbursement
|
Regulation
|
Healthcare Policy
|
Pharmacovigilance
|
Intellectual Property
|
Policy & Regulation
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
Europe must prioritise science, Spain tells EU competitiveness meeting
Today
Europe needs to act now and adopt "concrete R&D measures" to prevent scientific research leaving the EU, Cristina Garmendia , Spain's science and innovation minister, has warned on behalf of the Spanish presidency of the EU Council of Ministers. Asia threatens to overtake Europe in terms of innovation, and by 2025, the bulk of scientific research will be conducted outside of Europe, said Ms Garmendia on Sunday ahead of yesterday's informal meeting of competitiveness ministers. The meeting ...
 
Top Russian official sacked amid passing of new medicines law
Today
The Russian government has fired Nikolai Yurguel , the head of federal service on surveillance in healthcare and social development (Roszdravnadzor), saying that he has breached the law on civil services. However, its press service hinted that the actual reason was Mr Yurguel's public criticism ...
Novartis defends South Korean pricing of Glivec
05 February 2010
Novartis has rebutted suggestions that it has resisted attempts to reduce the cost of its leukaemia drug Glivec (imatinib) in South Korea. Information released through the website of Ip-health, giving the Korean Leukaemia Patient Group as a contact, stated that it had been "a long and tedious ...
 
Top Russian official sacked amid passing of new medicines law
Today
The Russian government has fired Nikolai Yurguel , the head of federal service on surveillance in healthcare and social development (Roszdravnadzor), saying that he has breached the law on civil services. However, its press service hinted that the actual reason was Mr Yurguel's public criticism ...
Ranbaxy's US facility gets FDA warning letter
08 February 2010
The US FDA 's recent warning letter to Ohm Laboratories over good manufacturing practice (GMP) deviations at its plant in Gloversville, New York, includes concerns over certain postmarketing and "unapproved" drug violations, as well as the lack of adequate personnel to ensure the completion of ...
 
Top Russian official sacked amid passing of new medicines law
Today
The Russian government has fired Nikolai Yurguel , the head of federal service on surveillance in healthcare and social development (Roszdravnadzor), saying that he has breached the law on civil services. However, its press service hinted that the actual reason was Mr Yurguel's public criticism ...
Ranbaxy's US facility gets FDA warning letter
08 February 2010
The US FDA 's recent warning letter to Ohm Laboratories over good manufacturing practice (GMP) deviations at its plant in Gloversville, New York, includes concerns over certain postmarketing and "unapproved" drug violations, as well as the lack of adequate personnel toensure the completion of ...
 
Top Russian official sacked amid passing of new medicines law
Today
The Russian government has fired Nikolai Yurguel , the head of federal service on surveillance in healthcare and social development (Roszdravnadzor), saying that he has breached the law on civil services. However, its press service hinted that the actual reason was Mr Yurguel's public criticism ...
Pharma could hide adverse drug reaction reports under EU plans, NGOs say
08 February 2010
Eight organisations representing consumers, health insurers, healthcare professionals and NGOs are worried that the European Commission's draft legislative proposals on pharmacovigilance could see pharmaceutical firms take up a bigger role in the collection and interpretation of adverse drug ...
 
Top Russian official sacked amid passing of new medicines law
Today
The Russian government has fired Nikolai Yurguel , the head of federal service on surveillance in healthcare and social development (Roszdravnadzor), saying that he has breached the law on civil services. However, its press service hinted that the actual reason was Mr Yurguel's public criticism ...
India continues efforts to stop unfair counterfeit laws in Africa
04 February 2010
India continues to use diplomatic channels to convince African nations against implementing legislation concerning counterfeit medicines that could fail to distinguish them from legitimate generic medicines. India's commerce department has recently held meetings on the issue with officials from a ...
 
EXPERT VIEW
The difference between legal and scientific substitutability
11 September 2009
Faraz Kermani
The tussle between Germany’s research-based pharmaceutical industry and health insurers over ...

Market Insight - Microdosing reaching a tipping point?
05 February 2010

Advocates of microdosing, a technique that involves testing very small doses of products in humans, ...

 Market Insight - How the IMI is reinvigoratin...
 Market Insight- The cost of donated drugs...

Market Insight- The cost of donated drugs
25 January 2010

The Haiti earthquake has led to a flurry of drug donations. As new World Health Organization ...

Market Insight - Originator/generic competition: who's the 'bad guy'?
28 January 2010

Intellectual property rights are key elements of the fierce competition between originator and ...

Comment: Is Bulgaria's decision to close hospitals premature?
04 February 2010
Bulgaria's government is close to implementing major changes to its national healthcare services to ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Spanish generics industry fights for its future
22 July 2009
Francesca Bruce
Spain's generic medicines industry could be in trouble. In 2008, for the first time since generics ...

Focus on Regulatory Affairs
10 September 2008
Advanced thinking - New regulation set to come into effect across the EU this December aims to ...

© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm